QQ客服 官方微博 反馈留言

	Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis
	Sun, Xiaoying; Roudi, Raheleh; Chen, Shangya; Fan, Bin; Li, Hong Jin; Zhou, Min; Li, Xin; Li, Bin
刊名	MEDICINE
	2017
卷号	96期号:44
关键词	immune-related adverse events inhibitors meta-analysis nonsmall cell lung cancer programmed cell death protein-1 programmed death-ligand 1 systematic review
ISSN号	0025-7974
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3639588
专题	上海中医药大学
推荐引用方式 GB/T 7714	Sun, Xiaoying,Roudi, Raheleh,Chen, Shangya,et al. Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis[J]. MEDICINE,2017,96(44).
APA	Sun, Xiaoying.,Roudi, Raheleh.,Chen, Shangya.,Fan, Bin.,Li, Hong Jin.,...&Li, Bin.(2017).Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis.MEDICINE,96(44).
MLA	Sun, Xiaoying,et al."Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis".MEDICINE 96.44(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。